CONCENTRATIONS OF APOLIPOPROTEIN A-I-CONTAINING PARTICLES IN PATIENTS WITH HYPOALPHALIPOPROTEINEMIA

被引:35
作者
MONTALI, A
VEGA, GL
GRUNDY, SM
机构
[1] UNIV TEXAS,SW MED CTR,CTR HUMAN NUTR,DALLAS,TX 75235
[2] UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235
[3] UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235
[4] UNIV TEXAS,SW MED CTR,DEPT CLIN NUTR,DALLAS,TX 75235
[5] VET AFFAIRS MED CTR,DALLAS,TX
来源
ARTERIOSCLEROSIS AND THROMBOSIS | 1994年 / 14卷 / 04期
关键词
APOA-I; HDL; LIPOPROTEINS;
D O I
10.1161/01.ATV.14.4.511
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was performed to determine relations among concentrations of high-density lipoprotein (HDL) apo-lipoprotein (apo) A-I and apoA-II and lipoproteins with apoA-I only (LpA-I) and with both apoA-I and apoA-II (LpA-I:A-II) in patients with low plasma levels of HDL cholesterol. Seventy-seven middle-aged men with low HDL cholesterol levels (<40 mg/dL) were compared with 37 middle-aged men with normal HDL cholesterol levels (>40 mg/dL). Low-HDL patients were divided into those with normotriglyceridemia (triglycerides <250 mg/dL; n=49) and hypertriglyceridemia (triglycerides greater-than-or-equal-to 250 mg/dL; n=28). Total apoA-I and apoA-II concentrations and apoA-I levels in LpA-I were significantly lower in the two low-HDL groups compared with control subjects. Although low-HDL patients' apoA-I levels were numerically lower in LpA-I:A-II compared with control subjects' levels, the differences were not statistically significant. Thus, there is a preferential reduction in apoA-I levels of LpA-I compared with LpA-I:A-II in patients with low HDL cholesterol. This preferential reduction in LpA-I levels was observed in both normotriglyceridemic and hypertriglyceridemic patients. However, among low-HDL patients levels of apoA-I in LpA-I did not distinguish between those with and without coronary heart disease.
引用
收藏
页码:511 / 517
页数:7
相关论文
共 31 条
[1]   HIGH-DENSITY LIPOPROTEINS IN MYOCARDIAL-INFARCTION SURVIVORS [J].
ALBERS, JJ ;
CHEUNG, MC ;
HAZZARD, WR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1978, 27 (04) :479-485
[2]   HIGH-DENSITY LIPOPROTEIN DISTRIBUTION - RESOLUTION AND DETERMINATION OF 3 MAJOR COMPONENTS IN A NORMAL POPULATION-SAMPLE [J].
ANDERSON, DW ;
NICHOLS, AV ;
PAN, SS ;
LINDGREN, FT .
ATHEROSCLEROSIS, 1978, 29 (02) :161-179
[3]  
AVORGARO P, 1979, LANCET, V1, P901
[4]   HIGH-DENSITY AND LOW-DENSITY LIPOPROTEIN SUBFRACTIONS IN SURVIVORS OF MYOCARDIAL-INFARCTION AND IN CONTROL SUBJECTS [J].
BALLANTYNE, FC ;
CLARK, RS ;
SIMPSON, HS ;
BALLANTYNE, D .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1982, 31 (05) :433-437
[5]   CHOLESTEROL EFFLUX FROM CULTURED ADIPOSE-CELLS IS MEDIATED BY LPAI PARTICLES BUT NOT BY LPAI-AII PARTICLES [J].
BARBARAS, R ;
PUCHOIS, P ;
FRUCHART, JC ;
AILHAUD, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 142 (01) :63-69
[6]   INCREASED APO-A-I AND APO-A-II FRACTIONAL CATABOLIC RATE IN PATIENTS WITH LOW HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL LEVELS WITH OR WITHOUT HYPERTRIGLYCERIDEMIA [J].
BRINTON, EA ;
EISENBERG, S ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :536-544
[7]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[8]  
CHEUNG MC, 1991, J LIPID RES, V32, P383
[9]  
COSTEBUREL M, 1990, CLIN CHEM, V36, P1889
[10]   PLASMA APOLIPOPROTEIN A-I, A-II, B, E AND C-III CONTAINING PARTICLES IN MEN WITH PREMATURE CORONARY-ARTERY DISEASE [J].
GENEST, JJ ;
BARD, JM ;
FRUCHART, JC ;
ORDOVAS, JM ;
WILSON, PFW ;
SCHAEFER, EJ .
ATHEROSCLEROSIS, 1991, 90 (2-3) :149-157